SCHEMBL7667906

SCHEMBL7667906

CC(C)(C)OC(=O)CNS(=O)(=O)c1ccc(NC(=O)c2ccc(F)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.56
MEN1 O00255 7/20 0.56
LMNA P02545 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
TDP1 Q9NUW8 1/20 0.54
TSHR P16473 1/20 0.52
HTT P42858 1/20 0.52
F2 P00734 1/20 0.50
TMPRSS6 Q8IU80 1/20 0.50
ALDH1A1 P00352 1/20 0.50
CTNNB1 P35222 1/20 0.49
TCF7L2 Q9NQB0 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
ATM Q13315 1/20 0.49
GAA P10253 1/20 0.48
USP30 Q70CQ3 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7670521 0.90 MEN1 (0.57) KMT2AMEN1LMNASMN1; SMN2F2
SCHEMBL5092484 0.90 MEN1 (0.55) KMT2AMEN1LMNASMN1; SMN2TDP1
SCHEMBL7667880 0.90 LMNA (0.54) KMT2AMEN1LMNASMN1; SMN2TDP1
SCHEMBL7667916 0.89 F2 (0.52) KMT2AMEN1LMNASMN1; SMN2TSHR
SCHEMBL7671859 0.89 PRMT1 (0.56) KMT2AMEN1LMNASMN1; SMN2F2
SCHEMBL7663740 0.88 ALDH1A1 (0.65) KMT2AMEN1LMNASMN1; SMN2F2
SCHEMBL7582747 0.88 LMNA (0.65) KMT2AMEN1LMNASMN1; SMN2F2
SCHEMBL6799380 0.88 ALDH1A1 (0.56) KMT2AMEN1LMNASMN1; SMN2TSHR
SCHEMBL7670801 0.88 LMNA (0.52) LMNASMN1; SMN2F2TMPRSS6ALDH1A1
SCHEMBL7580808 0.88 HSD17B10 (0.61) KMT2AMEN1LMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed